Pfizer Acquires Wyeth

Mergers, Acquisitions and Takeovers
Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, shake hands at a news conference discussing the planned merger of their companies January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion, creating the world's largest biopharmaceutical company. Photo by Mario Tama/Getty Images
Loading